Earnings Feed
Start Free
OSIRIS THERAPEUTICS, INC.·4

Feb 13, 5:35 PM ET

Debrabandere Lode 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Feb 13, 2013

Insider Transaction Report

Form 4
Period: 2013-02-12
OSIRIS THERAPEUTICS, INC.OSIR
Debrabandere Lode
Vice President
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2013-02-12$7.73/sh+18,064$139,635→ 210,564 total
    Exercise: $7.73From: 2014-02-12Exp: 2023-02-12→ Common Stock (18,064 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2013-02-12$7.73/sh+11,936$92,265→ 222,500 total
    Exercise: $7.73From: 2014-02-12Exp: 2023-02-12→ Common Stock (11,936 underlying)
Footnotes (1)
  • [F1]Options to purchase 30,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each Frebruary 12, 2014, 2015, 2016 and 2017, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -